Vrouyr Bilemjian/LinkedIn
Jan 30, 2024, 19:29
Vrouyr Bilemjian: We have developed a tumor targeting drug delivery systems
Vrouyr Bilemjian, Solutions and Strategy Consultant at Innoplexus, made the following post on LinkedIn:
“Excited to share my latest publication: ‘Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies‘.
Here in this research paper, we have developed a tumor targeting drug delivery systems, achieved by immobilizing Cetuximab and Atezolizumab on polysaccharide-based nanoparticles.
Grateful for the amazing team effort behind this research. Thank you all!”
Source: Vrouyr Bilemjian/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31